Faron Pharmaceuticals Oy (AIM:FARN)
London
· Delayed Price · Currency is GBP · Price in GBX 53.50
0.00 (0.00%)
At close: Mar 6, 2026
Faron Pharmaceuticals Oy Revenue
In the year 2025, Faron Pharmaceuticals Oy had annual revenue of 1.31M EUR.
Revenue
1.31M EUR
Revenue Growth
n/a
P/S Ratio
54.29
Revenue / Employee
40.88K EUR
Employees
32
Market Cap
61.94M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioventix | 13.12M |
| hVIVO | 54.47M |
| 4basebio | 1.78M |
| Ondine Biomedical | 1.18M |
| ImmuPharma | -69.96K |
| Scancell Holdings | 4.71M |
| Arecor Therapeutics | 5.06M |
| SkinBioTherapeutics | 4.64M |
Faron Pharmaceuticals Oy News
- 3 days ago - Faron Pharmaceuticals Oy (FRA:4FR) Full Year 2025 Earnings Call Highlights: Clinical Successes ... - GuruFocus
- 3 days ago - Full Year 2025 Faron Pharmaceuticals Oy Earnings Call Transcript - GuruFocus
- 8 months ago - Faron Pharmaceuticals To Earn Spotlight At IUIS 2025 With Its Bexmarilimab Data - IBTimes